Skip to content

Additive value of platelet rich plasma (PRP) in surgical treatment of stable vitiligo .A randomized double blind comparative study.

The value of adding platelet rich plasma (PRP) to non cultured epidermal cell suspension (NCES) in surgical treatment of stable vitiligo .A randomized double blind comparative study.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
PACTR
Registry ID
PACTR202108873035929
Enrollment
30
Registered
2021-08-16
Start date
2021-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin and Connective Tissue Diseases

Interventions

Non cultured epidermal suspension in platelet rich plasma

Sponsors

Dr. Dalia Abdel Halim
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with non-segmental stable vitiligo(NSV) with two comparable acral lesions, either symmetrical or in the same anatomical area. -patients with non acral vitiligo with lesions at elbows, knees or wrists. -Stability for = 1 year -Age >12years - patients not on treatment for at least 1 month prior to surgery.

Exclusion criteria

Exclusion criteria: Non acral vitiligo in areas other than elbows , knees and wrists . -Segmental vitiligo. - Acral vitiligo responsive to conventional treatment modalities - Active vitiligo; new lesions, expansion of old lesions or koebnerization in < 1 year - Age < 12 years. -pregnant and lactating females.

Design outcomes

Primary

MeasureTime frame
Assessing the additive value of PRP to NCES by comparing percent improvement in the lesion via point counting and Vitiligo Extent Score for target lesion VESTA Score .

Secondary

MeasureTime frame
- Assessing the possible influence of disease duration , the age of the patient , the extent of lesional pigmentation prior to therapy (VESTA) and duration of stability on the outcome of the NCES compared to the PRP enriched NCES in patients with stable vitiligo

Countries

Egypt

Contacts

Public ContactAhmed Fekry

faculty of medicine cairo university

drmedical101@yahoo.com00201113635646

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026